<bill session="114" type="h" number="4589" updated="2018-11-21T21:23:41Z">
  <state datetime="2016-02-23">REFERRED</state>
  <status>
    <introduced datetime="2016-02-23"/>
  </status>
  <introduced datetime="2016-02-23"/>
  <titles>
    <title type="short" as="introduced">Excellence in Medicare Act</title>
    <title type="short" as="introduced" partial="1">Medical Malpractice Reform Act of 2015</title>
    <title type="official" as="introduced">To amend title XVIII of the Social Security Act to repeal the cap on the Medicare Advantage star rating bonuses, and for other purposes.</title>
    <title type="display">Excellence in Medicare Act</title>
  </titles>
  <sponsor bioguide_id="M001193"/>
  <cosponsors>
    <cosponsor bioguide_id="C001103" joined="2016-02-25"/>
  </cosponsors>
  <actions>
    <action datetime="2016-02-23">
      <text>Introduced in House</text>
    </action>
    <action datetime="2016-02-23" state="REFERRED">
      <text>Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2016-02-23">
      <text>Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2016-02-23">
      <text>Referred to the Committee on the Judiciary, and in addition to the Committees on Energy and Commerce, and Ways and Means, for a period to be subsequently determined by the Speaker, in each case for consideration of such provisions as fall within the jurisdiction of the committee concerned.</text>
    </action>
    <action datetime="2016-02-23">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
    <action datetime="2016-02-26">
      <text>Referred to the Subcommittee on Health.</text>
    </action>
  </actions>
  <committees>
    <committee subcommittee="" code="HSIF" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="Health" code="HSIF14" name="House Energy and Commerce" activity="Referral"/>
    <committee subcommittee="" code="HSWM" name="House Ways and Means" activity="Referral"/>
    <committee subcommittee="Health" code="HSWM02" name="House Ways and Means" activity="Referral"/>
    <committee subcommittee="" code="HSJU" name="House Judiciary" activity="Referral"/>
  </committees>
  <relatedbills>
    <bill type="h" session="114" relation="unknown" number="4771"/>
    <bill type="h" session="114" relation="unknown" number="4275"/>
    <bill type="s" session="114" relation="unknown" number="3291"/>
  </relatedbills>
  <subjects>
    <term name="Health"/>
  </subjects>
  <amendments/>
  <summary date="2016-02-23T05:00:00Z" status="Introduced in House">Excellence in Medicare Act 

This bill amends title XVIII (Medicare)of the Social Security Act to require the Centers for Medicare &amp; Medicaid to disregard the application of certain percentage quality increases when calculating the maximum payment that may be made to a Medicare Advantage organization.

Medical Malpractice Reform Act of 2015

The bill sets conditions for lawsuits arising from health care liability claims regarding health care goods or services or any medical product affecting interstate commerce.Additionally, the bill sets a statute of limitations of three years after the date of manifestation of injury or one-year after the claimant discovers the injury, with certain exceptions.

The bill revises other provisions related to health care lawsuits including: (1)limiting noneconomic damages, (2)mandating joint and several liability, (3)limiting attorney contingency fees, (4) limiting punitive damages, and (5)denying punitive damages in the case of products approved by the Food and Drug Administration.</summary>
  <committee-reports/>
</bill>
